Astera Labs, Inc. (NASDAQ:ALAB) Receives $112.77 Consensus PT from Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus rating of “Buy” from the fourteen analysts that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $112.77.

Several analysts have recently commented on the stock. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Morgan Stanley decreased their price objective on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 28th. Stifel Nicolaus upped their price target on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, January 6th. Craig Hallum lifted their price objective on Astera Labs from $105.00 to $125.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Finally, Raymond James assumed coverage on shares of Astera Labs in a research report on Friday, March 14th. They set an “outperform” rating and a $82.00 target price on the stock.

Astera Labs Stock Performance

Astera Labs stock opened at $64.08 on Monday. The business’s fifty day moving average is $81.10 and its two-hundred day moving average is $90.61. The firm has a market cap of $10.39 billion and a P/E ratio of -37.04. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. On average, equities research analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Michael E. Hurlston sold 2,500 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total transaction of $230,200.00. Following the completion of the transaction, the director now directly owns 91,794 shares of the company’s stock, valued at $8,452,391.52. This represents a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 350,680 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total value of $31,389,366.80. Following the transaction, the chief executive officer now directly owns 2,353,655 shares of the company’s stock, valued at approximately $210,675,659.05. This trade represents a 12.97 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 570,990 shares of company stock worth $50,242,702.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC boosted its holdings in shares of Astera Labs by 99.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after buying an additional 99 shares during the period. Whittier Trust Co. of Nevada Inc. acquired a new stake in Astera Labs during the fourth quarter worth approximately $25,000. Kestra Investment Management LLC acquired a new stake in Astera Labs during the fourth quarter worth approximately $28,000. GAMMA Investing LLC increased its stake in shares of Astera Labs by 78.3% during the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock worth $68,000 after purchasing an additional 224 shares during the period. Finally, CIBC Asset Management Inc lifted its holdings in Astera Labs by 5.2% during the 4th quarter. CIBC Asset Management Inc now owns 4,757 shares of the company’s stock worth $630,000 after purchasing an additional 237 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.